These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11551871)

  • 1. Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins.
    van 't Hooft FM; Ruotolo G; Boquist S; de Faire U; Eggertsen G; Hamsten A
    Circulation; 2001 Sep; 104(11):1223-8. PubMed ID: 11551871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An apolipoprotein A-II polymorphism (-265T/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men.
    Delgado-Lista J; Perez-Jimenez F; Tanaka T; Perez-Martinez P; Jimenez-Gomez Y; Marin C; Ruano J; Parnell L; Ordovas JM; Lopez-Miranda J
    J Nutr; 2007 Sep; 137(9):2024-8. PubMed ID: 17709437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
    Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
    Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
    Castellani LW; Goto AM; Lusis AJ
    Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study.
    Corella D; Arnett DK; Tsai MY; Kabagambe EK; Peacock JM; Hixson JE; Straka RJ; Province M; Lai CQ; Parnell LD; Borecki I; Ordovas JM
    Clin Chem; 2007 Jun; 53(6):1144-52. PubMed ID: 17446329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOA II genotypes frequency and their interaction with saturated fatty acids consumption on lipid profile of patients with type 2 diabetes.
    Noorshahi N; Sotoudeh G; Djalali M; Eshraghian MR; Keramatipour M; Basiri MG; Doostan F; Koohdani F
    Clin Nutr; 2016 Aug; 35(4):907-11. PubMed ID: 26210798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: a negative regulatory effect is reversed by GABP, an Ets-related protein.
    Cardot P; Pastier D; Lacorte JM; Mangeney M; Zannis VI; Chambaz J
    Biochemistry; 1994 Oct; 33(40):12139-48. PubMed ID: 7918435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha.
    Skoog T; van't Hooft FM; Kallin B; Jovinge S; Boquist S; Nilsson J; Eriksson P; Hamsten A
    Hum Mol Genet; 1999 Aug; 8(8):1443-9. PubMed ID: 10400991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.
    Boquist S; Ruotolo G; Tang R; Björkegren J; Bond MG; de Faire U; Karpe F; Hamsten A
    Circulation; 1999 Aug; 100(7):723-8. PubMed ID: 10449694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2.
    Tam SP; Zhang X; Cuthbert C; Wang Z; Ellis T
    J Lipid Res; 1997 Oct; 38(10):2090-102. PubMed ID: 9374131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subfractions: The ECTIM study.
    Brousseau T; Dupuy-Gorce AM; Evans A; Arveiler D; Ruidavets JB; Haas B; Cambou JP; Luc G; Ducimetière P; Amouyel P; Helbecque N
    Am J Med Genet; 2002 Jun; 110(1):19-24. PubMed ID: 12116266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
    Julve J; Escolà-Gil JC; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    Biochim Biophys Acta; 2000 Nov; 1488(3):233-44. PubMed ID: 11082533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men.
    Jiménez-Gómez Y; Pérez-Jiménez F; Marín C; Gómez P; Moreno R; Delgado J; Pérez-Martínez P; Gómez MJ; López-Miranda J
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):173-81. PubMed ID: 17399967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the metabolism of plasma lipoproteins by apolipoprotein A-II.
    Wang J; Kitagawa K; Kitado H; Kogishi K; Matsushita T; Hosokawa M; Higuchi K
    Biochim Biophys Acta; 1997 Apr; 1345(3):248-58. PubMed ID: 9150245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region.
    Lacorte JM; Fourniat E; Pastier D; Chambaz J; Ribeiro A; Cardot P
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):681-8. PubMed ID: 8809063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription.
    Cardot P; Chambaz J; Kardassis D; Cladaras C; Zannis VI
    Biochemistry; 1993 Sep; 32(35):9080-93. PubMed ID: 8369280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.